Clinical • MSi-H Biomarker • Circulating tumor DNA • Metastases
|
HER-2 (Human epidermal growth factor receptor 2) • KRAS (KRAS proto-oncogene GTPase) • BRAF (B-raf proto-oncogene) • TP53 (Tumor protein P53) • PIK3CA (Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) • MET (MET proto-oncogene, receptor tyrosine kinase) • NRAS (Neuroblastoma RAS viral oncogene homolog) • MSI (Microsatellite instability) • FGFR1 (Fibroblast growth factor receptor 1) • NF1 (Neurofibromin 1) • SMAD4 (SMAD family member 4) • FBXW7 (F-Box And WD Repeat Domain Containing 7) • APC (APC Regulator Of WNT Signaling Pathway)
|
TP53 mutation • KRAS mutation • MSI-H/dMMR • BRAF mutation • MET amplification • RAS mutation
|
AlphaLiquid® 100
|
Xalkori (crizotinib) • Cabometyx (cabozantinib tablet) • Tabrecta (capmatinib)